• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Innovaderm Research Inc. - Product Pipeline Review - Q4 2010 - Product Image

Innovaderm Research Inc. - Product Pipeline Review - Q4 2010

  • Published: November 2010
  • 26 pages
  • Global Markets Direct

Innovaderm Research Inc. – Product Pipeline Review – Q4 2010

Summary

Global Market Direct’s pharmaceuticals report, “Innovaderm Research Inc. - Product Pipeline Review - Q4 2010” provides data on the company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Innovaderm Research Inc. - Brief company overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Innovaderm Research Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination READ MORE >



List of Tables
List of Figures
Innovaderm Research Inc. Snapshot
Innovaderm Research Inc. Overview
Key Information
Key Facts
Innovaderm Research Inc. – Research and Development Overview
Key Therapeutic Areas
Innovaderm Research Inc. – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Innovaderm Research Inc. – Pipeline Products Glance
Innovaderm Research Inc. – Late Stage Pipeline
Phase III Products/Combination Treatment Modalities
Innovaderm Research Inc. – Drug Profiles
Humira
Product Description
Mechanism of Action
R&D Progress
Infliximab
Product Description
Mechanism of Action
R&D Progress
Methylaminolevulinate
Product Description
Mechanism of Action
R&D Progress
Xeomin
Product Description
Mechanism of Action
R&D Progress
Innovaderm Research Inc. – Pipeline Analysis
Innovaderm Research Inc. – Pipeline Products by Therapeutic Class
Innovaderm Research Inc. Pipeline Products By Target
Innovaderm Research Inc. – Pipeline Products by Route of Administration
Innovaderm Research Inc. – Recent Pipeline Updates
Innovaderm Research Inc. – Locations And Subsidiaries
Head Office
Recent Developments
Nov 05, 2010: Merz To Present Data On Xeomin At 71st Annual Assembly Of American Academy Of Physical Medicine And Rehabilitation
Sep 20, 2010: Merz Pharma Launches XEOMIN Patient Assistance Plan In Canada
Sep 20, 2010: Merz Pharma Launches XEOMIN Patient Assistance Plan In Canada
Sep 07, 2010: MERZ Pharma's XEOMIN Listed With Regular Benefit Status On AHWDBL
Sep 07, 2010: MERZ Pharma's XEOMIN Listed With Regular Benefit Status On AHWDBL
Aug 02, 2010: Merz Receives FDA Approval For Xeomin For Treatment Of Cervical Dystonia
Jun 23, 2010: MERZ Pharma's Xeomin Receives Limited Coverage Drug Status From British Columbia's Ministry of Health Services
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

Note: Product cover images may vary from those shown

RELATED PRODUCTS